However, BC patients with CDKN1A, RHOB, DDB1, AHNAK, ANP32A and MKI67 genes harboring somatic mutations had relatively longer DFS when compared with unaltered group (Supplementary Figure 5 and Supplementary Table 3). This evidence concerns the gene ANP32A and breast cancer.